Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy

American Journal of Cardiology

Volumn 119, Issue 3, 2017, Pages 483-489

  Bobbo, Marco ^a   Pinamonti, Bruno ^a   Merlo, Marco ^a   Stolfo, Davide ^a   Iorio, Annamaria ^a   Ramani, Federica ^a   Barbati, Giulia ^a   Carriere, Cosimo ^a   Massa, Laura ^a   Poli, Stefano ^a   Scapol, Sara ^a   Gigli, Marta ^a   Di Lenarda, Andrea ^b   Sinagra, Gianfranco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; HYPERTENSIVE HYPOKINETIC CARDIOMYOPATHY; IDIOPATHIC DISEASE; LEFT VENTRICULAR ASSIST DEVICE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; AGED; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CAUSE OF DEATH; COMPLICATION; DISEASE COURSE; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HYPERTROPHY, LEFT VENTRICULAR; MORTALITY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINERALOCORTICOID ANTAGONIST;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CAUSE OF DEATH; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MORTALITY; RETROSPECTIVE STUDIES; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION; VENTRICULAR REMODELING;

EID: 85007559200     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.10.014     Document Type: Article

References (30)

1. 1 Frohlich, E.D., Apstein, C., Chobanian, A.V., Devereux, R.B., Dustan, H.P., Dzau, V., Fauad-Tarazi, F., Horan, M.J., Marcus, M., Massie, B., Pfeffer, M.A., Re, R.N., Roccella, E.J., Savage, D., Shub, C., The heart in hypertension. N Engl J Med 327 (1992), 998–1008.
2. 2 Yip, G.W., Fung, J.W.H., Tan, Y.T., Sanderson, J.E., Hypertension and heart failure: a dysfunction of systole, diastole or both?. J Hum Hypertens 23 (2009), 295–306.
3. 3 Lip, G.Y., Felmeden, D.C., Li-Saw-Hee, F.L., Beevers, D.G., Hypertensive heart disease. A complex syndrome or a hypertensive “cardiomyopathy”?. Eur Heart J 21 (2000), 1653–1665.
4. 4 Maron, B.J., Towbin, J.A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A.J., Seidman, C.E., Young, J.B., Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart failure and Transplantation Committee: Quality of Care and Outcomes Reseasrch and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006), 1807–1816.
5. 5 Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W.J., Monserrat, L., Pankuweit, S., Rapezzi, C., Seferovic, P., Tavazzi, L., Keren, A., Classification of the cardiomyopathies; a position statement from the European Society of cardiology working group on Myocardial and Pericardial Diseases. Eur Heart J 29 (2008), 270–276.
6. 6 Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., Galderisi, M., Grobbee, D.E., Jaarsma, T., Kirchhof, P., Kjeldsen, S.E., Laurent, S., Manolis, A.J., Nilsson, P.M., Ruilope, L.M., Schmieder, R.E., Sirnes, P.A., Sleight, P., Viigimaa, M., Waeber, B., Zannad, F., 2013 ESH/ESC Guidelines for the management of arterial hypertension: TheTask Force for the management ofarterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31 (2013), 1281–1357.
7. 7 Anzini, M., Merlo, M., Sabbadini, G., Barbati, G., Finocchiaro, G., Pinamonti, B., Salvi, A., Perkan, A., Di Lenarda, A., Bussani, R., Bartunek, J., Sinagra, G., Long-term evolution and prognostic stratification of biopsy-proven active myocarditis. Circulation 128 (2013), 2384–2394.
8. 8 Weiner, D.E., Krassilnikova, M., Tighiouart, H., Salem, D.N., Levey, A.S., Sarnak, M.J., CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study. BCM Nephrol, 10, 2009, 26.
9. 9 Merlo, M., Cannatá, A., Vitagliano, A., Zambon, E., Lardieri, G., Sinagra, G., Clinical management of dilated cardiomyopathy: current knowledge and future perspectives. Expert Rev Cardiovasc Ther 14 (2016), 137–140.
10. 10 McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M.A., Jaarsma, T., Køber, L., Lip, G.Y., Maggioni, A.P., Parkhomenko, A., Pieske, B.M., Popescu, B.A., Rønnevik, P.K., Rutten, F.H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P.T., Voors, A.A., Zannad, F., Zeiher, A., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33 (2012), 1787–1847.
11. 11 Lang, R., Badano, L., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F.A., Foster, E., Goldstein, S.A., Kuznetsova, T., Lancellotti, P., Muraru, D., Picard, M.H., Rietzschel, E.R., Rudski, L., Spencer, K.T., Tsang, W., Voigt, J.U., Recommendations for cardiac chamber Quantification by echocardiography in Adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (2015), 1–39.
12. 12 Pinamonti, B., Di Lenarda, A., Sinagra, G., Camerini, F., Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group. J Am Coll Cardiol 22 (1993), 808–815.
13. 13 Lancellotti, P., Moura, L., Pierard, L.A., Agricola, E., Popescu, B.A., Tribouilloy, C., Hagendorff, A., Monin, J.L., Badano, L., Zamorano, J.L., European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 11 (2010), 307–332.
14. 14 Stolfo, D., Merlo, M., Pinamonti, B., Poli, S., Gigli, M., Barbati, G., Fabris, E., Di Lenarda, A., Sinagra, G., Early improvement of functional mitral regurgitation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 115 (2015), 1137–1143.
15. 15 Merlo, M., Pyxaras, S.A., Pinamonti, B., Barbati, G., Di Lenarda, A., Sinagra, G., Prevalence and prognostic significance of left ventricular reverse remodelling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 57 (2011), 1468–1476.
16. 16 Devereux, R.B., Alonso, D.R., Lutas, E.M., Gottlieb, G.J., Campo, E., Sachs, I., Reichek, N., Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986), 450–458.
17. 17 Merlo, M., Gobbo, M., Stolfo, D., Losurdo, P., Ramani, F., Barbati, G., Pivetta, A., Di Lenarda, A., Anzini, M., Gigli, M., Pinamonti, B., Sinagra, G., The prognostic impact of the evolution of RV function in idiopathic DCM. JACC Cardiovasc Imaging 9 (2016), 1034–1042.
18. 18 Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., de Ferranti, S., Després, J.P., Fullerton, H.J., Howard, V.J., Huffman, M.D., Judd, S.E., Kissela, B.M., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Liu, S., Mackey, R.H., Matchar, D.B., McGuire, D.K., Mohler, E.R. 3rd, Moy, C.S., Muntner, P., Mussolino, M.E., Nasir, K., Neumar, R.W., Nichol, G., Palaniappan, L., Pandey, D.K., Reeves, M.J., Rodriguez, C.J., Sorlie, P.D., Stein, J., Towfighi, A., Turan, T.N., Virani, S.S., Willey, J.Z., Woo, D., Yeh, R.W., Turner, M.B., Heart disease and Stroke Statistics—2015 update. A report from the American Heart Association. Circulation 131 (2015), e29–e322.
19. 19 Hein, S., Arnon, E., Kostin, S., Schönburg, M., Elsässer, A., Polyakova, V., Bauer, E.P., Klövekorn, W.P., Schaper, J., Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107 (2003), 984–991.
20. 20 Norton, G.R., Woodiwiss, A.J., Gaasch, W.H., Mela, T., Chung, E.S., Aurigemma, G.P., Meyer, T.E., Heart failure in pressure overload hypertrophy. J Am Coll Cardiol 39 (2002), 664–671.
21. 21 Drazner, M.H., The transition from hypertrophy to heart failure: how certain we are?. Circulation 112 (2005), 936–938.
22. 22 Drazner, M.H., The progression of hypertensive heart disease. Circulation 123 (2011), 327–334.
23. 23 Milani, R.V., Drazner, M.H., Lavie, C.J., Morin, D.P., Ventura, H.O., Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction. Am J Cardiol 108 (2011), 992–996.
24. 24 Tracy, C.M., Epstein, A.E., Darbar, D., Dimarco, J.P., Dunbar, S.B., Estes, N.A. 3rd, Ferguson, T.B. Jr., Hammill, S.C., Karasik, P.E., Link, M.S., Marine, J.E., Schoenfeld, M.H., Shanker, A.J., Silka, M.J., Stevenson, L.W., Stevenson, W.G., Varosy, P.D., 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 60 (2012), 1297–1313.
25. 25 Zecchin, M., Merlo, M., Pivetta, A., Barbati, G., Lutman, C., Gregori, D., Serdoz, L.V., Bardari, S., Magnani, S., Di Lenarda, A., Proclemer, A., Sinagra, G., How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with “SCD-HeFT criteria”?. Am J Cardiol 109 (2012), 729–735.
26. 26 Masci, P.G., Doulaptsis, C., Bertella, E., Del Torto, A., Symons, R., Pontone, G., Barison, A., Droogné, W., Andreini, D., Lorenzoni, V., Gripari, P., Mushtaq, S., Emdin, M., Bogaert, J., Lombardi, M., Incremental prognostic value of myocardial fibrosis in patients with non–Ischemic cardiomyopathy without Congestive heart failure. Circ Heart Fail 7 (2014), 448–456.
27. 27 Masci, P.G., Schuurman, R., Andrea, B., Ripoli, A., Coceani, M., Chiappino, S., Todiere, G., Srebot, V., Passino, C., Aquaro, G.D., Emdin, M., Lombardi, M., Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy. A contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging 6 (2013), 790–799.
28. 28 Sinagra, G., Anzini, M., Pereira, N.L., Bussani, R., Finocchiaro, G., Bartunek, J., Merlo, M., Myocarditis in clinical practice. Mayo Clin Proc 91 (2016), 1256–1266.
29. 29 Merlo, M., Pivetta, A., Pinamonti, B., Stolfo, D., Zecchin, M., Barbati, G., Di Lenarda, A., Sinagra, G., Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail 16 (2013), 317–324.
30. 30 Aneja, A., Tang, W.H., Bansilal, S., Garcia, M.J., Farkouh, M.E., Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121 (2008), 748–775.